Surmodics Announces New Credit Facilities Providing up to $125 Million in Financing
Copyright 2022, Business Wire.
news
2022-10-17 12:30:00

October 17, 2022 08:30 AM Eastern Daylight Time EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it has entered into a new, five-year credit agreement with MidCap Financial ('MidCap'), comprised of up to $100 million in term loans and a $25 million revolving credit facility.



'We are pleased to significantly improve our access to capital on favorable, non-dilutive terms with credit facilities that provide increased borrowing capacity and financial flexibility,' said Gary Maharaj, President and CEO of Surmodics, Inc.
